BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7700896)

  • 1. Predictive factors for the rate of engraftment of neuroblastoma patients autotransplanted with purged marrow.
    Ross RE; Jeter EK; Gazitt Y; Laver J
    Prog Clin Biol Res; 1994; 389():139-43. PubMed ID: 7700896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients.
    Canals C; Puntí C; Picón M; Amill B; Tugues D; Sanchez T; Badell I; Pardo N; Ortega J; Vivancos P
    Prog Clin Biol Res; 1992; 377():289-96. PubMed ID: 1438427
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recovery.
    Faulkner LB; Lindsley KL; Kher U; Heller G; Black P; Finlay JL
    Bone Marrow Transplant; 1996 Mar; 17(3):389-94. PubMed ID: 8704692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of single and double immunomagnetic depletion on the hemopoietic capacity of marrow in patients with advanced neuroblastoma submitted to autologous bone marrow transplantation.
    Lopez M; Zucker JM; Urresola R; Douay L; Quintana E; Kemshead J; Gorin NC; Vilcoq JR
    Bone Marrow Transplant; 1987 Dec; 2(4):413-9. PubMed ID: 3332188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
    Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
    Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood stem cell transplantation in young children: experience with harvesting, mobilization and engraftment.
    Kletzel M; Longino R; Rademaker AW; Danner-Koptik KE; Olszewski M; Morgan ER
    Pediatr Transplant; 1998 Aug; 2(3):191-6. PubMed ID: 10084741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of parameters affecting engraftment in children undergoing autologous peripheral blood stem cell transplants.
    Figuerres E; Haut PR; Olzewski M; Kletzel M
    Bone Marrow Transplant; 2000 Mar; 25(6):583-8. PubMed ID: 10734291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
    Damon LE; Rugo HS; Ries CA; Linker CA
    Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very long delay to engraftment after ABMT in neuroblastoma patients and effect of CD8 monoclonal antibody in vivo therapy.
    Favrot MC; Philip T; Combaret V; Biron P; Morisset J; Bernard A
    Prog Clin Biol Res; 1988; 271():225-36. PubMed ID: 3043450
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
    Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
    Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
    Skala JP; Rogers PC; Chan KW; Chao HY; Rodriguez WC
    Prog Clin Biol Res; 1992; 377():71-8. PubMed ID: 1438447
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.
    Cheung IY; Lo Piccolo MS; Collins N; Kushner BH; Cheung NK
    Cancer; 2002 Jun; 94(11):3042-8. PubMed ID: 12115395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A direct and effective immunomagnetic method for bone marrow purging in non-T ALL malignancies. The use of an anti-HLA-DR antibody gives sustained engraftment.
    Wang MY; Fodstad O; Funderud S; Bengtsson M; Totterman T; Ludwig WD; Martin H; Kvalheim G
    Prog Clin Biol Res; 1994; 389():119-24. PubMed ID: 7700893
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL).
    Martín-Henao GA; Picón M; Limón A; Carmona M; Amill B; Azqueta C; López R; González-Barca E; Grañena A; Brunet S; García J
    Bone Marrow Transplant; 1999 Mar; 23(6):579-87. PubMed ID: 10217189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.